Cosmetic FDA regulations changed dramatically when the U.S. Congress passed the Modernization of Cosmetics Regulation Act (MoCRA), giving FDA new powers over the cosmetics industry. Now, MoCRA primarily defines the framework for how cosmetic products are registered, labeled, and sold.
In this guide, we discuss everything from facility registration to adverse event reporting for cosmetic brands, helping manufacturers understand FDA requirements and avoid regulatory penalties in the US market.

Facility Registration: The First Compliance Box to Check
Every manufacturer or processor of cosmetic products sold in the U.S. must register their facility with the FDA. This includes both domestic and foreign facilities. Registrations must be renewed every two years
- Deadline Watch: New facilities must register within 60 days of beginning manufacturing or processing activities.
- Rolling Clock: Registrations must be renewed every two years to keep compliance active.
- Registrations are submitted through FDA’s Cosmetics Direct portal or via paper Forms FDA 5066 (for product listing) and 5067 (for facility registration).
- Each facility receives an FDA Establishment Identifier (FEI) number.
Who Gets a Pass?
MoCRA carves out exemptions for certain small businesses, but these come with important caveats.
Businesses averaging less than $1 million in gross annual sales of cosmetic products during the previous 3-year period may qualify; this number is adjusted for inflation periodically.
However, this exemption does NOT apply if the business manufactures or processes:
- Cosmetics intended for use near or in the eye (mascara, eyeliner, etc.)
- Products for internal use (cosmetic injections, oral cosmetics, beauty supplements, etc.)
- Products that alter appearance for over 24 hours (dyes, acrylic/gel nails, etc.)
Check Out: ISO 22716 Certification – CGA GMP Process

Product Listing: Tell the FDA What You’re Selling
The “responsible person” (defined as the manufacturer, packer, or distributor whose name appears on the product label) must submit a listing for each marketed cosmetic product.
- What to Include: Each listing must include the product name, category, ingredients (including fragrances and colorants), and the facility where it’s made.
- Even free samples and gift-with-purchase items generally require a product listing.
- Multiple buildings can share one FEI number if they are within 3 miles of each other, under common management, and inspectable in a single FDA visit.
- Listings must be updated annually and whenever a product is discontinued.
Every Word On The Labeling Is Regulated
Cosmetic labeling in the U.S. is governed by the FD&C Act, the Fair Packaging and Labeling (FP&L) Act, and MoCRA.
The Non-Negotiable Label Elements
- Product identity: What it is (e.g., “moisturizing lotion”)
- Net quantity of contents – in both metric and U.S. customary units
- Name and place of business of the responsible person
- Domestic contact information (as of Dec 29, 2024 under MoCRA) so consumers can report adverse events directly.
- Ingredient declaration: Ingredients must be listed in descending order of predominance using INCI (International Nomenclature of Cosmetic Ingredients) names
- Any required warnings – such as for products containing alpha hydroxy acids (AHAs) or professional-use items
- Labels must be clear and prominent

Common Labeling Mistakes That Trigger FDA Action
30-40% of cosmetics in the US market have to face recalls due to branding and labelling discrepancies. Common reasons include:
- Using incorrect INCI names or listing ingredients out of descending order = labeling violation
- Making drug claims like saying your serum “treats eczema” or “regenerates cells” immediately reclassifies your product as a drug, requiring full FDA drug approval.
- Making “organic” claims. You must comply with USDA regulations on top of FDA requirements
- The term “cosmeceutical” has no legal standing; don’t use it on your label
- Missing warning statements
Explore: Gluten-Free Certification for Cosmetics
Safety Substantiation: Prove Your Product Won’t Cause Harm
Cosmetic FDA regulations as per MoCRA require that every product be substantiated for safety before it hits the market.
This means maintaining records that demonstrate a reasonable certainty of safety under the product’s intended conditions of use and making those records available to the FDA upon request.
- What Records to Keep: Safety substantiation records must support both the product as a whole and its individual ingredients at their used concentrations.
- Testing data, published literature, supplier safety data sheets, and expert toxicological assessments all count as supporting documentation.
- No formal FDA-approved testing protocol for cosmetics is mandated, but your evidence must be credible and complete.
Pro tip: If you’re sourcing contract-manufactured products, confirm in your supplier agreements who holds the safety substantiation records and ensure you have access to them.

Adverse Event Reporting: When Things Go Wrong, You Have 15 Days
Under MoCRA, responsible persons must submit reports of serious adverse events to the FDA within 15 business days of receiving a consumer complaint. A “serious adverse event” includes bodily harm requiring medical treatment, hospitalization, disability, or life-threatening outcomes.
- The report must be filed using MedWatch Form 3500A.
- Maintain records of both serious and non-serious adverse events.
Good Manufacturing Practices (GMP), FDA, and MoCRA: Pending Laws
The Modernization of Cosmetics Regulation Act (MoCRA) authorizes the FDA to establish mandatory Good Manufacturing Practice (GMP) regulations for cosmetic products. However, the FDA has not yet issued a final GMP rule, and mandatory GMP requirements for cosmetics are not currently in effect.
FDA does outline certain GMP regulations under the Federal Food, Drug and Cosmetic Act. As per these guidelines,
- Everything from buildings and equipment to labelling, complaints, and ingredient management are to be regulated as per GMP laws.
- Products that do not follow GMP requirements are to be adulterated under the FD&C Act sec. 601(f).
Until the FDA issues the final GMP rule, there is no mandatory federal GMP standard for cosmetics, though voluntary compliance with ISO 22716:2007 is widely recommended.
Explore GMP certifications in more detail here.
What’s Banned and What’s Being Watched
Unlike many jurisdictions, the FDA does not pre-approve most cosmetic ingredients, except for color additives and a limited number of prohibited or restricted substances. Besides these, products from any raw material can be used and marketed as cosmetics.
- Ingredients prohibited by the FDA include bithionol, mercury compounds, vinyl chloride, halogenated salicylanilides, zirconium complexes in aerosol cosmetics, chloroform, methylene chloride, chlorofluorocarbon propellants and hexachlorophene.
- Many ingredients are also currently under scrutiny owing to health concerns.
You Might Also Like: Vegan Certification for Cosmetics: Requirements and Process – Carat Global Assurance

Navigating the State-by-State Regulations
One of the major compliance challenges for cosmetic brands is the growing patchwork of state-level regulations.
MoCRA preempts certain state requirements but allows states to adopt additional ingredient restrictions and consumer protection measures in specific areas.
- Washington’s Toxic-Free Cosmetics Act (TFCA): Restricts PFAS, formaldehyde-releasing preservatives, phthalates, and other harmful substances.
- California’s Safe Cosmetics Program: Requires disclosure of ingredients linked to cancer, birth defects, or reproductive harm, with its own reporting portal California Safe Cosmetics Program.
- New York & Maine: Have introduced restrictions on PFAS and require transparency labeling that go beyond federal minimums.
If you’re selling nationwide, your compliance team needs to track both the FDA rulebook and active state legislation simultaneously.
Cosmetic vs. Drug: The Line That Can Upend Your Entire Business
This is arguably the most dangerous gray area in the industry.
- How FDA defines a cosmetic: “articles intended to be rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise applied to the human body…for cleansing, beautifying, promoting attractiveness, or altering the appearance” [FD&C Act, sec. 201(i)]” (Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?) | FDA)
- How FDA defines a drug: “articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease” and “articles (other than food) intended to affect the structure or any function of the body of man or other animals” [FD&C Act, sec. 201(g)(1)].
The moment a cosmetic product claim crosses into preventing or treating a disease, or affecting body structure or function, it becomes a drug.
Claim Comparison:
| Cosmetic Claim | Drug Claim |
| Moisturizes skin | Treats eczema |
| Covers blemishes | Clears acne |
| Improves appearance | Regenerates skin cells |
Crossing this line, even unintentionally, can trigger mandatory drug approval requirements, FDA warning letters, and import holds. Review every touchpoint: product labels, website copy, social media, and influencer briefs.
Check Out: Vegan Certification for Cosmetics: Benefits & Process

Importing Cosmetics? Here’s What Customs Is Looking For
Cosmetics offered for import into the U.S. must comply with the exact same cosmetic FDA regulations as domestically produced products.
At the border, FDA entry reviewers verify compliance using your entry transmission data.
- Declared manufacturer, importer/consignee, product description, and Affirmation of Compliance (A of C) codes are all cross-referenced against FDA’s internal systems.
- Labeling must be in English (Spanish in Puerto Rico), declare all required information truthfully, and contain no drug claims.
Pro tip: Work with a regulatory consultant or certification body that has cross-border compliance expertise before your first U.S. shipment.
What to Expect in 2026 and 2027?
Passed in 2022, MoCRA regulations have been becoming more stringent over time. Here’s what to expect in the coming months.
- Disclosing fragrance allergens: Compliance deadlines expected around late 2026 or early 2027.
- Renew Registrations: MoCRA facility registrations require renewal every two years.
- Prepare for Talc Testing: Review testing procedures and maintain supporting records.
- Track New FDA Rules: Monitor upcoming GMP and fragrance allergen regulations.
Frequently Asked Questions (FAQs)
The FDA does not pre-approve most cosmetic products or ingredients before they’re sold. However, color additives used in cosmetics must receive explicit FDA approval before use.
The responsible person is the manufacturer, packer, or distributor whose name appears on the product label. This entity holds the primary compliance obligations: product listing, safety substantiation, and adverse event reporting. In the case of private-label brands, this is typically the brand owner, not the contract manufacturer.
No. “Natural,” “organic,” or “clean” claims do not exempt a product from FDA regulatory requirements. “Organic” labeling requires separate USDA compliance. All cosmetics, regardless of ingredient origin, must meet FD&C Act, FP&L Act, and MoCRA requirements.
Obtaining a GMP certification builds your compliance infrastructure ahead of FDA’s upcoming mandatory cGMP rules. It demonstrates operational quality to regulators and retail buyers, and can streamline additional certifications (Halal, Vegan, Gluten-Free) through an integrated audit process. Learn how CGA’s integrated audit approach works here.
Yes. Under MoCRA, the FDA has expanded authority to inspect cosmetic manufacturing and processing facilities and may review safety and quality control records. Companies should maintain organized documentation and be prepared to demonstrate compliance during an FDA inspection.
Can’t find what you’re looking for?
